Content
A $50B AI Drug Discovery Revolution Has Begun - Here Are 6 Stocks To Consider Investing In
Article By:
Lorimer Wilson
Read
Monday, May 20, 2024 12:30 PM EDT
The drug development process is very expensive and time-consuming which creates a huge shortage in drug candidates and programs but the advent of AI can significantly shorten and cheapen this process and this is already happening.
Crocodile Tears
Article By:
Angry Bear
Read
Monday, May 20, 2024 7:16 AM EDT
Numerous Americans have found themselves ensnared in analogous predicaments while seeking medical attention. The opacity surrounding healthcare pricing makes it difficult for patients to ascertain the cost of their care upfront.
Week In Review: Takeda Options Alzheimer's Therapy From AC Immune In $2.2 Billion Deal
Article By:
ChinaBio® Today
Read
Sunday, May 19, 2024 7:14 PM EDT
In the headline deal, Takeda acquires global rights from AC Immune of Switzerland for $100 million upfront and up to $2.1B in milestones.
American Cannabis MSOs Portfolio Reversed Direction Last Week
Article By:
Lorimer Wilson
Read
Sunday, May 19, 2024 4:45 PM EDT
This article highlights how each constituent in the Portfolio fared last week and MTD along with their reported Q1 profit or loss and their Q1 adjusted EBITDA as a percentage of quarterly revenue for comparison purposes:
Walgreens Boots Alliance, Inc. Dividend Stock Analysis
Article By:
Dividends4Life
Read
Friday, May 17, 2024 6:15 AM EDT
Walgreens Boots Alliance, Inc. is the largest U.S. retail drug chain in terms of revenues, this company operates more than 8,000 drug stores throughout the U.S. and Puerto Rico.
In this article: WBA
Current Analysis: Smith & Nephew
Article By:
Fredrik Arnold
Read
Thursday, May 16, 2024 11:40 PM EDT
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Over the past year, SNN's share price fell about 9.4% from $32.50 to $25.84 as of Thursday’s market close.
In this article: SNN
3 Stocks To Buy Following Positive Earnings Results
Article By:
Derek Lewis
Read
Thursday, May 16, 2024 11:20 PM EDT
Total earnings for the S&P 500 members that have reported Q1 results are up +4.8% from the same period last year on +4.1% higher revenues. The earnings growth pace reflects an acceleration relative to other periods
Which Is The Best Investment For You? High Yield Pfizer Or Higher Growth Merck?
Video By:
Chuck Carnevale
Watch
Thursday, May 16, 2024 3:30 PM EDT
It depends on what your goals, objectives, and risk tolerances are.
Thoughts For Thursday: New Highs Are Here
Article By:
David Marshall
Read
Thursday, May 16, 2024 5:09 AM EDT
New highs are here. The stock market interpreted the "positive" CPI data as a sign for lower interest rates down the line and the market took, off global unrest seemingly of no concern to investors.
Current Analysis: MediPal Holdings Corporation
Article By:
Fredrik Arnold
Read
Wednesday, May 15, 2024 10:05 PM EDT
MediPal Holdings Corp (MAHLY) distributes pharmaceuticals, and health and beauty products to medical institutions and retailers. Over the past year, MediPal share price fell about 9.4% from $15.56 to $15.22 as of Wednesday’s market close.
In this article: MAHLY
AYR Wellness' Q1 Financials Reveal 94% Reduction In Net Loss
Article By:
Lorimer Wilson
Read
Wednesday, May 15, 2024 5:06 PM EDT
First quarter results reflect continued progress with modest sequential revenue growth, adjusted EBITDA margins in line with long-term targets of 25% and positive free cash flow for the period.
In this article: AYRWF
All Cresco Labs' QI Financial Metrics Down Except SG&A
Article By:
Lorimer Wilson
Read
Wednesday, May 15, 2024 12:51 PM EDT
Despite the poor Q1 financial report Cresco's stock price is UP 2.5% as of mid-day but is still DOWN 1.9% from last Friday albeit UP 52.6% YTD.
In this article: CRLBF
Current Analysis: Fresenius Medical Care
Article By:
Fredrik Arnold
Read
Wednesday, May 15, 2024 6:15 AM EDT
Fresenius Medical Care is the largest dialysis company in the world and a leading supplier of dialysis products, including machines, dialyzers, and concentrates.
In this article: FMS
Organigram Q2 Financial Metrics Mixed
Article By:
Lorimer Wilson
Read
Tuesday, May 14, 2024 2:00 PM EDT
Of the top 3 licensed producers in Canada Organigram is the only one with significant cash, negligible debt, and sizeable funds earmarked for strategic international investment.
In this article: OGI
J&J: A Healthy Dose Of Income And Growth
Article By:
MoneyShow.com
Read
Tuesday, May 14, 2024 3:30 AM EDT
Johnson & Johnson (JNJ)— founded in 1886 — is a diversified healthcare company and a leader in the area of innovative medicine and medical devices.
In this article: JNJ